Max Robotics — Global Service Robot Directory + US Certification

About

Stefano Del Prato is a leading figure in diabetes research and medical robotics, whose work bridges cutting-edge bioengineering with clinical endocrinology. His primary research areas include implantable medical devices for metabolic regulation, intraperitoneal insulin delivery systems, and the pathophysiology of pancreatic endocrine disorders. Del Prato’s most notable contribution is his pioneering work on a fully implantable device for intraperitoneal drug delivery that can be refilled by ingestible capsules—a breakthrough with 64 citations that promises to revolutionize type 1 diabetes management by restoring blood glucose homeostasis without the burden of daily injections. This innovation addresses a critical challenge in medical robotics: creating autonomous, long-term solutions for replacing physiological processes. In addition, Del Prato has made significant clinical contributions, including his study on the rare coexistence of nesidioblastosis and insulinoma (13 citations), which sheds light on diagnostic and therapeutic dilemmas in hyperinsulinemic hypoglycemia. His work is characterized by a unique synergy between engineering and patient care, offering tangible hope for improved quality of life in diabetes. Del Prato’s research continues to inspire interdisciplinary approaches to chronic disease management, positioning him as a transformative voice in both biomedical engineering and endocrinology.